Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5265794
Max Phase: Preclinical
Molecular Formula: C17H17NO4
Molecular Weight: 299.33
Associated Items:
ID: ALA5265794
Max Phase: Preclinical
Molecular Formula: C17H17NO4
Molecular Weight: 299.33
Associated Items:
Canonical SMILES: CCCOc1cccc(C(=O)Nc2ccccc2C(=O)O)c1
Standard InChI: InChI=1S/C17H17NO4/c1-2-10-22-13-7-5-6-12(11-13)16(19)18-15-9-4-3-8-14(15)17(20)21/h3-9,11H,2,10H2,1H3,(H,18,19)(H,20,21)
Standard InChI Key: XETQFQDCOSMESO-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 299.33 | Molecular Weight (Monoisotopic): 299.1158 | AlogP: 3.43 | #Rotatable Bonds: 6 |
Polar Surface Area: 75.63 | Molecular Species: ACID | HBA: 3 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 3.55 | CX Basic pKa: | CX LogP: 4.09 | CX LogD: 0.73 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.86 | Np Likeness Score: -1.25 |
1. Shalaby MW, Dokla EME, Serya RAT, Abouzid KAM.. (2020) Penicillin binding protein 2a: An overview and a medicinal chemistry perspective., 199 [PMID:32442851] [10.1016/j.ejmech.2020.112312] |
Source(1):